Cour Pharmaceuticals, the Chicago-based clinical-stage biotechnology company, says its first patient has been dosed in the phase 1b/2a clinical trial of a treatment that it hopes will address ...
On July 13, the folks at SUR Restaurant and Lounge posted a huge update to the restaurant's Instagram page. The photo featured one of the restaurant's owners, Guillermo Zapata, with the EC Twins, a ...
Windows 11 might be the latest version of Windows, but if you still use Windows 10 and need to "clean install" the operating system, or install or upgrade to it for the first time on an older PC, ...
Here's the full breakdown of the features you get from Windows 10 Home and Pro. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Update February 3 ...
Shares of online learning platform Coursera (NYSE:COUR) fell 12.7% in the afternoon session after the company reported underwhelming fourth quarter results. Its revenue and EBITDA guidance for the ...
CNP-104 is a biodegradable nanoparticle that previously received fast track designation from FDA in January 2022, which would eventually make it eligible for accelerated approval and priority review.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has granted Cour Pharmaceuticals orphan drug ...
I remain bullish on Coursera stock, expecting growth to accelerate to mid-teens by FY26, driven by improving macro conditions and robust demand. The macro environment in the US and Europe is ...
A pharmaceutical company plans to jump from one Chicago suburb to another as demand for life science space in the Chicago metro shows promise but possible saturation. COUR Pharmaceuticals signed a ...
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Coursera, Inc. (NYSE:COUR) ranks among the best growth stocks under $10 to buy. After a ...
We all know that some perfectly good Windows 10 PCs can't be upgraded to Windows 11. Did you know, however, that Canalys Insights last year estimated that 240 million Windows 10 PCs are doomed to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results